Iowa · J0702

Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg in Iowa

Iowa Medicare Avg
$4.76
3% below national avg
National Medicare Avg
$4.88
All states combined
Billed Charge (IA)
$15.44
What providers submit
Est. Commercial (IA)
$13.26
National avg: $14.56
Est. Cash / Self-Pay (IA)
$9.10
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

15.3K
Services in IA
123
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Iowa

Provider Medicare Services
Vittetoe, David MD $4.63 1.8K
Mann, Tobias M.D. $4.89 1.5K

Iowa Pricing in Context

In Iowa, CPT code J0702 (Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg) carries an average Medicare payment of $4.76 — 3% below the national benchmark of $4.88. 123 providers across the state submitted claims for this procedure in 2023, performing 15.3K total services. Individual payments in IA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Iowa is $15.44, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Iowa sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Iowa lands near $13.26, with self-pay cash prices typically around $9.10. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg cost in Iowa?

The average Medicare payment for Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg in Iowa is $4.76, which is 3% below the national average of $4.88. Providers in IA typically bill $15.44 for this procedure.

What does Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg cost with insurance in Iowa?

With commercial insurance in Iowa, Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg costs an estimated $13.26. Without insurance, the estimated cash price is $9.10. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg in Iowa?

123 providers in Iowa billed Medicare for Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg in 2023, performing 15.3K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg cheaper in Iowa than the national average?

Yes — Injection, Betamethasone Acetate 3 Mg And Betamethasone Sodium Phosphate 3 Mg costs 3% below the national average in Iowa. The state average Medicare payment is $4.76 compared to $4.88 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial